The tariff classification of Penicillin G Potassium for Injection in dosage form, from Italy

N328937 November 16, 2022 CLA-2-29:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.10.1020 Mrs. Robyn K. Brunciak WorldGen LLC 120 Route 17 North Paramus, NJ 07652 RE: The tariff classification of Penicillin G Potassium for Injection in dosage form, from Italy Dear Mrs. Brunciak: In your letter dated October 24, 2022, you requested a tariff classification ruling. Penicillin G Potassium for Injection, imported in 20 mmu/l00 mL vials, is the potassium salt form of penicillin G, a broad-spectrum penicillin antibiotic. It is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms causing septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis, anthrax, actinomycosis, botulism, diphtheria, erysipelothrix, endocarditis and fusospirochetosis. The applicable subheading for the Penicillin G Potassium for Injection in dosage form will be 3004.10.1020, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives: Containing penicillin G salts: Other: Singles.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division